Ogsiveo (nirogacestat) — United Healthcare
Desmoid tumors
Initial criteria
- Diagnosis of desmoid tumor
- Disease is progressive
- Patient requires systemic treatment
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Ogsiveo therapy
Approval duration
12 months